alexa
Reach Us +44-1904-929220
Diagnostics Of Sepsis- Biomarkers Sought For Sepsis Management | 8937
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Diagnostics of sepsis- biomarkers sought for sepsis management

4th International Conference on Biomarkers & Clinical Research

Miroslav Prucha

AcceptedAbstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.019

Abstract
S epsis is a serious high mortality disease. As regards pathophysiology, it is a systemic inflammatory response to infection. Its timely diagnosis strongly influences mortality. The identification of biomarkers is used for diagnosing, monitoring, and prognosis in septic patients. The methods for their measurement cover a range of disciplines such as clinical biochemistry, hematology, immunology, and clinical microbiology. The most frequently used sepsis markers in routine clinical diagnostics are C-reactive protein and procalcitonin. The detection of selected cytokines, mediators, and surface markers in immunocompetent cells gives us further chance for improvement of this diagnostics. The methods of calculating gene expression represent a technology with a potential for the discovery of new biomarkers which would improve both diagnostics and therapy in the sense of personalized medicine.
Biography
Miroslav Prucha is currently an Associate Professor of Clinical Immunology at Hospital na Homolce, Prague, Czech Republic. He got his Medicine Doctor ́s degree (Ph.D.) at Masaryk ́s University, Brno, Czech Republic. He has more than 20 years of personal experience in different leadership positions in the clinical immunology, clinical chemistry, and laboratory medicine field. He has been involved in a multitude of clinical trials in the field of sepsis - diagnostics and therapy and asthma bronchiale and autoimmune diseases
Relevant Topics
Top